Companies / Rocket Pharmaceuticals, Inc. / Activity
Activity — Rocket Pharmaceuticals, Inc.
9 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | Shah Gaurav CEO | Sell | Common Stock | $171.8K | -56K -4.98% | 1,061,724 0.97% of shares | medium |
| May 21, 2026 | Shah Gaurav CEO | Exercise | Common Stock | $129.3K | +76K +7.35% | 1,117,408 1.02% of shares | low |
| Feb 13, 2026 | Shah Gaurav CEO | Sell | Common Stock | $40.7K | -12K -1.15% | 1,052,045 0.96% of shares | low |
| Feb 18, 2026 | Shah Gaurav CEO | Sell | Common Stock | $20.0K | -6K -0.57% | 1,046,055 0.95% of shares | low |
| May 13, 2026 | Shah Gaurav CEO | Sell | Common Stock | $9.8K | -3K -0.26% | 1,043,327 0.95% of shares | low |
| May 19, 2026 | Shah Gaurav CEO | Sell | Common Stock | $7.3K | -2K -0.23% | 1,040,918 0.95% of shares | low |
| Feb 11, 2026 | Shah Gaurav CEO | Grant | Common Stock | $0 | +286K +36.75% | 1,064,324 0.97% of shares | low |
| May 21, 2026 | Shah Gaurav CEO | Exercise | Stock Option (Right to Buy) | — | -76K -100.00% | 0 0.00% of shares | low |
| Feb 11, 2026 | Shah Gaurav CEO | Grant | Stock Option (Right to Buy) | — | +871K | 870,648 0.79% of shares | low |